Olin Corp (OLN):企業の財務・戦略的SWOT分析

◆英語タイトル:Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8338
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Olin Corp (OLN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Olin Corp (Olin) manufactures and distributes chemical products. Its product offering includes chlorine, caustic soda, methyl chloride, ethylene dichloride and vinyl chloride monomer, chloroform, methylene chloride, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrogen, hydrochloric acid, bleach products and potassium hydroxide. Olin produces epoxy materials including allyl chloride, liquid epoxy resins, epichlorohydrin, solid epoxy resins and additives. The company’s chemicals are widely used chemicals, which are further upgraded into a wide variety of downstream chemical products. It also produces and markets reloading components, sporting ammunition, small caliber military ammunition and components, and industrial cartridges. The company has operations in the US, Canada, South Korea, Germany, Italy, Australia, the Netherlands and Brazil. Olin Corp is headquartered in Clayton, Missouri, the US.

Olin Corp Key Recent Developments

Sep 20,2018: Scott M. Sutton appointed to Olin’s Board of Directors
Jul 31,2018: Olin announces second quarter 2018 earnings
May 01,2018: Olin Announces First Quarter 2018 Earnings
May 01,2018: Olin Announces First Quarter 2018 Earnings
Apr 25,2018: Olin Announces New Lead Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Olin Corp – Key Facts 6
Olin Corp – Key Employees 7
Olin Corp – Key Employee Biographies 8
Olin Corp – Major Products and Services 9
Olin Corp – History 10
Olin Corp – Company Statement 11
Olin Corp – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Olin Corp – Business Description 14
Business Segment: Chlor Alkali Products and Vinyls 14
Overview 14
Performance 14
Business Segment: Epoxy 14
Overview 14
Performance 14
Business Segment: Winchester 15
Overview 15
Performance 15
Geographical Segment: Foreign 15
Performance 15
Geographical Segment: The US 15
Performance 15
Olin Corp – Corporate Strategy 16
Olin Corp – SWOT Analysis 17
SWOT Analysis – Overview 17
Olin Corp – Strengths 17
Olin Corp – Weaknesses 18
Olin Corp – Opportunities 19
Olin Corp – Threats 20
Olin Corp – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Petrochemicals Financial Deals and Alliances 29
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals By Type, 2012 to YTD 2018 30
Olin Corp, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Sep 20, 2018: Scott M. Sutton appointed to Olin’s Board of Directors 32
Jul 31, 2018: Olin announces second quarter 2018 earnings 33
May 01, 2018: Olin Announces First Quarter 2018 Earnings 35
May 01, 2018: Olin Announces First Quarter 2018 Earnings 37
Apr 25, 2018: Olin Announces New Lead Director 39
Feb 06, 2018: Olin Announces Fourth Quarter 2017 Earnings 40
Feb 06, 2018: Olin Announces Fourth Quarter 2017 Earnings 43
Aug 31, 2017: Olin Declares Force Majeure For Product Shipments From Freeport, Texas 46
Jul 31, 2017: Olin Announces Second Quarter 2017 Earnings And Reiterates Full Year 2017 Guidance 47
Jun 19, 2017: Olin Updates Second Quarter 2017 Outlook 49
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Olin Corp, Key Facts 6
Olin Corp, Key Employees 7
Olin Corp, Key Employee Biographies 8
Olin Corp, Major Products and Services 9
Olin Corp, History 10
Olin Corp, Subsidiaries 12
Olin Corp, Key Competitors 21
Olin Corp, Ratios based on current share price 22
Olin Corp, Annual Ratios 23
Olin Corp, Annual Ratios (Cont...1) 24
Olin Corp, Annual Ratios (Cont...2) 25
Olin Corp, Interim Ratios 27
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals By Type, 2012 to YTD 2018 30
Olin Corp, Recent Deals Summary 31
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53

List of Figures
Olin Corp, Performance Chart (2013 - 2017) 26
Olin Corp, Ratio Charts 28
Olin Corp, Petrochemicals, Deals By Year, 2012 to YTD 2018 29
Olin Corp, Petrochemicals, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Olin Corp (OLN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pon Holdings B.V.:企業のM&A・事業提携・投資動向
    Pon Holdings B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pon Holdings B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Ali Baba:企業の戦略・SWOT・財務情報
    Ali Baba - Strategy, SWOT and Corporate Finance Report Summary Ali Baba - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Msig Holdings (Asia) Pte. Ltd.:企業の戦略・SWOT・財務分析
    Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • InterDigital, Inc. (IDCC):企業の財務・戦略的SWOT分析
    InterDigital, Inc. (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務分析
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fortis Inc (FTS):企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Purdue Pharma L.P.:企業のM&A・事業提携・投資動向
    Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Meiji Holdings Co, Ltd.:戦略・SWOT・企業財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinic …
  • SeQuent Scientific Ltd (512529):企業の財務・戦略的SWOT分析
    Summary SeQuent Scientific Ltd (SeQuent) is a pharmaceutical company that develops and manufactures animal health API, life science and industrial products. The company offers products such as aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium and dihydroartem …
  • Asian Hotels (North) Limited:企業の戦略・SWOT・財務情報
    Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report Summary Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • TFS Financial Corp:企業の戦略・SWOT・財務分析
    TFS Financial Corp - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mediaset S.p.A.:企業の戦略・SWOT・財務情報
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bc Hydro
    Bc Hydro - Strategy, SWOT and Corporate Finance Report Summary Bc Hydro - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Virtusa Corp (VRTU):企業の財務・戦略的SWOT分析
    Virtusa Corp (VRTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Waters Corp (WAT):企業の財務・戦略的SWOT分析
    Waters Corp (WAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American National Insurance Co:企業の戦略・SWOT・財務情報
    American National Insurance Co - Strategy, SWOT and Corporate Finance Report Summary American National Insurance Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆